APA (7th ed.) Citation

CL, C., G, M., M, Y., TS, P., ML, N., RW, C., . . . CL, P. (2025). Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. EBioMedicine, 114, 105647. https://doi.org/10.1016/j.ebiom.2025.105647

Chicago Style (17th ed.) Citation

CL, Cooper, et al. "Preclinical Development of a Replication-competent Vesicular Stomatitis Virus-based Lassa Virus Vaccine Candidate Advanced into Human Clinical Trials." EBioMedicine 114 (2025): 105647. https://doi.org/10.1016/j.ebiom.2025.105647.

MLA (9th ed.) Citation

CL, Cooper, et al. "Preclinical Development of a Replication-competent Vesicular Stomatitis Virus-based Lassa Virus Vaccine Candidate Advanced into Human Clinical Trials." EBioMedicine, vol. 114, 2025, p. 105647, https://doi.org/10.1016/j.ebiom.2025.105647.